Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists

Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists

US Patent 6579876 · Granted Jun 17, 2003

Estimated economic value: $426,875,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligonucleotides targeting alpha-synuclein and uses thereof2025
Antisense oligonucleotides targeting alpha-synuclein and uses thereof2024
Oligonucleotides for modulating Tau expression2024
Phosphorus (V)-based reagents, processes for the preparation thereof, and their 2024
Salts and processes of preparing a PI3K inhibitor2024
Substituted bicyclic compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Solid forms of an HPK1 inhibitor2023
Methods of selecting therapeutic molecules2023
Oligonucleotides for modulating Tau expression2023
Substituted naphthyridinone compounds useful as T cell activators2023
Phosphorous (V)-based reagents, processes for the preparation thereof, and their2023